Cartron, G., Houot, R., Tabaa, Y. A., Bras, F. L., Ysebaert, L., Choquet, S., Camus, V., Bay, J., Gros, F., Morschhauser, F., Casasnovas, O., Gastinne, T., Thieblemont, C., Joris, M., Ricard, L., Regny, C., Rochelle, L. D. L., Feugier, P., Marcais, A., Griolet, S., Tarte, K., Laurent, C., Sesques, P. (2025). Glofitamab for patients with Non–Large B-cell lymphoma refractory or relapsing after anti-CD19 CAR T-cell therapy: Final bicar study (LYSA) results.. Blood. https://doi.org/10.1182/blood-2025-5923